Select Your Region
- Manufacturer: Evonik Corporation
- Product Line: LACTEL® Polymers
- Product: LACTEL® PLGE Polymers
- Industries: Pharmaceuticals
- Authorized Countries: Canada | United States
LACTEL® 85:15 DL-PLGE, IV 0.76-0.85
Evonik's LACTEL® 85:15 DL-PLGE, IV 0.76-0.85 is a specialized pharmaceutical controlled-release agent designed with a blend of 85% D,L-lactide and 15% glycolide with an inherent viscosity of 0.76─0.85 dL/g in chloroform. It offers excellent stability with an extended degradation period of 9 months.
Quantity
Documents
Specifications
Physical state: Solid
Form: Granules or pellets
Color: White to yellowish, off-white to light tan
Inherent viscosity (IV) dL/g: 0.76─0.85 (in chloroform)
Degradation time: <12 months
Density (g/mL): 1.27
Tensile Strength (psi): 6000─8000
Elongation (%): 3─10
Modulus (psi): 2─4x10⁵
CAS No. 26780-50-7
Primary Chemistry:
Poly(DL-lactide-co-glycolide)
- Manufacturer: Evonik Corporation
- Product Line: LACTEL® Polymers
- Product: LACTEL® PLGE Polymers
- Industries: Pharmaceuticals
- Authorized Countries: Canada | United States
Manufacturer
Product Line
Product
Industries
Authorized Countries
Canada
United States
Overview
LACTEL® 85:15 DL-PLGE, IV 0.76-0.85 is a biocompatible and biodegradable PLGA copolymer with an ester end group and no added preservatives. As part of Evonik's LACTEL® polymer line, it offers exceptional controlled release of pharmaceutical ingredients in long-acting injectable formulations for human generic drug formulations and veterinary medicine with high functionality and advanced metabolization for controlled drug release.
Specifications
Physical state: Solid
Form: Granules or pellets
Color: White to yellowish, off-white to light tan
Inherent viscosity (IV) dL/g: 0.76─0.85 (in chloroform)
Degradation time: <12 months
Density (g/mL): 1.27
Tensile Strength (psi): 6000─8000
Elongation (%): 3─10
Modulus (psi): 2─4x10⁵
CAS No. 26780-50-7
Primary Chemistry:
Poly(DL-lactide-co-glycolide)
Features & Benefits
- 85:15 ratio of D,L-Lactide and Glycolide
- Ester end group
- 12-month degradation time
- Biodegradable
- Ideal for terminal sterilization
- Bioabsorbable excipient
- Suitable for use with small molecules, peptides, proteins, and other substances
- Non-GMO
- No added preservatives
- Cost effective
Applications
Human generic drug formulations
Long-acting injectable formulations
Price sensitive applications
veterinary medicine
Related Applications
Pharmaceuticals
Related Functions
Pharmaceuticals
ChemPoint is here to help
Are you in the correct region?
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region: English - United States
